Remove top-10-most-anticipated-drug-launches-2023
article thumbnail

Can Singapore become a global hub for biotech?

Drug Discovery World

According to Statista, revenue in this sector is expected to grow at an annual rate of 6.77%, resulting in a market volume of US$2,208m by 2028 1. The government’s Biomedical Sciences (BMS) initiative was launched in June 2000, focused on boosting industries such as pharmaceuticals, biotechnology, medical technology, and healthcare.

article thumbnail

Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics

XTalks

Understanding the market dynamics of diabetes treatments becomes crucial for professionals across these industries. The top 15 diabetes drugs in 2023, according to 2022 sales data, reflect the current state of diabetes management and hint at the evolving needs and trends within this critical area of healthcare.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference

The Pharma Data

The company has the ambition to deliver double-digit topline growth through 2025, targeting $9 to $10 billion in global revenue. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Amidst COVID-19 pressures throughout 2020, Alexion added more than 700 U.S.

article thumbnail

Top 10 Fastest Growing Biotech Companies in 2023

XTalks

In 2023, biotechnology and pharmaceutical companies leverage cutting-edge technology and significant investments in research and development (R&D) to continue pushing the boundaries of innovation in the healthcare sector, transcending the challenges posed by the pandemic. billion, in contrast to the same quarter in 2022.

Genetics 111
article thumbnail

The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments

FDA Law Blog

Valentine — Few FDA publications are as eagerly anticipated in the drug development world as the twice-a-decade PDUFA Reauthorization Performance Goals and Procedures (hereinafter the “goals letter”). However, the hiring targets drop dramatically in both centers in each subsequent FY after FY 2023.

article thumbnail

Top 10 Medical Device Companies in 2023 by Revenue Statistics and Trends

XTalks

This article takes a comprehensive look at the top 10 medical device companies that are leading the charge in this rapidly evolving field. Join us as we explore the inspiring journey and significant contributions of these top 10 medical device companies. It also plans to launch these products in the US.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine. RELATED: Top 10 Medical Device Companies in 2023: Statistics and Trends 1) Pfizer By: Nadia Stec, M.Sc. billion in 2022, a 23.43 billion, a 42.74

Sales 98